Effects of ezetimibe in association with statins on postprandial lipemia in type 2 diabetic patients - Ezetimibe effects on postprandial lipemia

IVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II0 个研究点开始时间: 2009年5月25日最近更新: 2012年4月3日

试验速览

暂无简介。

•- Type 2 diabetes since at least two years - Stable metabolic control (HbA1c<8.0%) for at least six months on diet or diet+oral hypoglycemic drugs (insulin secretagogues or metformin), not to be changed during the study period. - BMI<30 kg/m2 and body weight stable during the last six months. - Both sexes; only post-menopausal women. - LDL-cholesterol >130 mg/dl, plasma triglycerides <400 mg/dl. - No use of hypolipidemic drugs in the last three months.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•- Patient with renal (serum creatinine >1.5 mg/dl) or hepatic (serum transaminases >three times upper normal values) impairment. - Patients with history of cardiovascular disease. - Pre-menopausal women. - Any other acute or chronic degenerative disease. - Anemia (Hb<12 g/dl). - Uncontrolled blood pressure. - Use of any drugs able to interfere with the study medications.

发起方

IVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II